Category Archives: Uncategorized @en


Biomedical research reform: the Jardé law

06

Nov 2017

Biomedical research reform: the Jardé law

The Jardé law, voted in March 2012, aims at giving a legal and statutory framework to clinical trials which involve people. Universal Medica summarizes for you the main points of the decree number 2017-884 of May 9th, 2017 which modifies certain arrangements. Creation of 3 new categories With the Jardé law, the “Biomedical Research (called in French RBM)” changed of name to be now called…

Read More


What is medical information?

04

Oct 2017

What is medical information?

The primary role of medical information is to provide an answer to enquiries made by healthcare professionals and patients. The nature of their questions can be : Medical: Therapeutic Indications, Contraindications, Posology, Interactions with other medicinal products Pharmaceutical: dosage form, pharmacology, storage conditions… Crisis management-related: batch recall, stock shortage, etc. Find out more about the services provided by Universal Medical in the field of medical…

Read More


Pharmacovigilance and Drug Safety in France

08

Sep 2017

Pharmacovigilance and Drug Safety in France

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem to enhance patient care and patient safety in relation to the use of medicines. Learn more about our pharmacovigilance services.


Meet Universal Medica at DIA Euromeeting 2015 – April 13, 14 &15 2015

30

Jan 2015

Meet Universal Medica at DIA Euromeeting 2015 – April 13, 14 &15 2015

This year, Universal Medica is attending to the 27 th DIA Annual Euromeeting on 13 to 15 april 2015. What is DIA 2015? DIA Euromeeting is the opportunity to reach the full range of medicines development professionnals. From pharmaceuticals and biotech industry to CROs, regulators froms EMA, FDA and euopean countries national regulatory agencies and many others, DIA allows you to discuss with your present…

Read More


Happy New Year 2015 from Universal Medica Group

06

Jan 2015

Happy New Year 2015 from Universal Medica Group

Universal Medica Group wishes you a prosperous and successful New Year, full of joy and happiness. 2014 has been full of challenges, we are looking forward new opportunities to cooperate with you in order to face the new ones that 2015 may hold ! Internet of things, life science solutions, digital health communication, big & open data, interactive disease : Click on the the cherry…

Read More


Innovation Prize 2014 Finalist iTeos concludes a deal with Pfizer

10

Dec 2014

Innovation Prize 2014 Finalist iTeos concludes a deal with Pfizer

We are proud to announce that one of the 5 finalists of the Innovation Prize 2014 has concluded a deal of $ 25 million with the pharmaceutical company, Pfizer. This Belgian society, iTeos Therapeutics lead by Michel Detheux, develops Indoleamine 2,3 Dioxygenase(IDO1) and Tryptophan – 2,3-Dioxygenase (TDO2) drug candidates. This news highlights the quality of the projects submitted during the Innovation Prize and recognizes the…

Read More